Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Tuesday Jan 09, 2024
Tuesday Jan 09, 2024
touchFOCUS for touchONCOLOGY
Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them.
The expert:
- Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Regeneron. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com/
Tuesday Jan 09, 2024
Tuesday Jan 09, 2024
touchFOCUS for touchRESPIRATORY
Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them.
The expert:
- Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Regeneron. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratoryime.org/
Monday Jan 08, 2024
Monday Jan 08, 2024
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy.
This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com/
Monday Jan 08, 2024
Monday Jan 08, 2024
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchhaematologyime.org/
Friday Dec 22, 2023
Advances in IOL technology and power calculations: Updates and innovations
Friday Dec 22, 2023
Friday Dec 22, 2023
touchFOCUS for touchOPHTHALMOLOGY
Listen to Dr John Hovanesian answer a series of questions focused on how to effectively manage patients prior to cataract surgery and ensure the most appropriate intraocular lens (IOL) formula is used, including his views on recent advances in IOL technology.
The expert:
- Dr John Hovanesian, University of California, Los Angeles, Jules Stein Eye Institute, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC,. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchophthalmologyime.org/advances-in-iol-technology-and-power-calculations-updates-and-innovations/
Wednesday Dec 13, 2023
Guideline-based treatment of recurrent/metastatic cervical cancer
Wednesday Dec 13, 2023
Wednesday Dec 13, 2023
touchEXPERT OPINIONS for touchONCOLOGY
Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments.
The experts
- Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA
- Dr Domenica Lorusso - La Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy,
- Courtney Arn – The Ohio State University, Columbus, OH, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Merck and Co., Inc and Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org/guideline-management-recurrent-metastatic-cervical-cancer
Monday Dec 11, 2023
IgG4-related disease: How to identify, diagnose and treat
Monday Dec 11, 2023
Monday Dec 11, 2023
touchSATELLITE SYMPOSIUM for touchIMMUNOLOGY
Listen to this touchSATELLITE SYMPOSIUM recorded live in November at the ACR Convergence 2023, in San Diego, CA, USA.
Prof. John Stone (USA), the chair for the symposium, is joined by Dr Emanuel Della Torre (Italy) and Dr Arezou Khosroshahi (USA).
The first session, led by Prof. John Stone (02:27), focuses on the pathophysiology and varying clinical presentations of IgG4-related disease (IgG4-RD). This is followed by an audience Q&A (13:11).
The second session, led by Dr Emanuel Della Torre (15:43), reviews the classification criteria for IgG4-RD and how to diagnose the condition. This is followed by an audience Q&A (25:22).
In the third session, Dr Arezou Khosroshahi (29:53) looks at how to treat IgG4-RD and discusses the optimal use of glucocorticoids to induce and maintain remission, and summarizes the targeted treatments for IgG4-RD that are in clinical development. This is followed by an audience Q&A (39:51).
The symposium concludes with a panel discussion and a case presentation (44:06).
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunologyime.org/igg4-related-disease-identify-diagnose-treat/
Thursday Dec 07, 2023
Paediatric atopic dermatitis: Evolving strategies for improved management
Thursday Dec 07, 2023
Thursday Dec 07, 2023
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms.
The experts
- Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA
- Assist. Prof. Nives Pustišek - Children’s Hospital, Zagreb, Croatia
- Prof. Andreas Wollenberg - Ludwig-Maximilian University, Munich, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunologyime.org
Thursday Dec 07, 2023
Paediatric atopic dermatitis: Evolving strategies for improved management
Thursday Dec 07, 2023
Thursday Dec 07, 2023
touchPANEL DISCUSSION for touchDERMATOLOGY
Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms.
The experts
- Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA
- Assist. Prof. Nives Pustišek - Children’s Hospital, Zagreb, Croatia
- Prof. Andreas Wollenberg - Ludwig-Maximilian University, Munich, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchdermaime.org
Wednesday Dec 06, 2023
Wednesday Dec 06, 2023
touchEXPERT OPINIONS for touchNEUROLOGY
A leading multiple sclerosis (MS) specialist shares key considerations for a personalized treatment strategy for patients with relapsing forms of MS, and goes on to explore the key role that B cells play in the pathogenesis and progression of MS, including the therapeutic potential of B-cell–targeted agents.
The expert
- Prof. Martin Weber, University Medical Center Göttingen, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit: touchneurologyime.org/eo-update-on-optimizing-management-of-rms